NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
September 6, 2024 — Assisted Reproductive Technology Testing Outcomes During COVID Travel Lockdown - Summary of outcomes, research, and services provided by the Bedford Research Foundation.
September 5, 2024 — PayMedix/TempoPay announces the appointment of David Kinsey as Vice President of Sales, signaling a period of accelerated growth. Kinsey will lead sales initiatives for innovative healthcare payment solutions.
September 5, 2024 — New study shows up to 74% of participants with resistant high blood pressure improved control within 12 months using a remote monitoring system and pharmacist interactions.
September 5, 2024 — Preliminary research abstracts presented at the American Heart Association’s Hypertension Scientific Sessions 2024 reveal the concerning prevalence of high blood pressure and unmet social needs among young adults and children in the U.S.
September 5, 2024 — Preliminary research presented at the American Heart Association’s Hypertension Scientific Sessions 2024 reveals that at-home blood pressure monitor cuffs may not fit millions of U.S. adults, particularly in the Black community. The study underscores the importance of addressing disparities in cuff sizes for accurate blood pressure monitoring.
September 5, 2024 — Telomir Pharmaceuticals Inc. (NASDAQ: TELO) is gaining attention for its promising age reversal drug compound, Telomir-1, which has shown positive outcomes in a study with senior dogs. CEO Erez Aminov is dedicated to advancing the research necessary to bring this treatment to humans and pets.
September 5, 2024 — Mainz Biomed N.V. and Liquid Biosciences have teamed up to potentially add pancreatic cancer detection to the ColoAlert® screening test. This collaboration represents a significant step in the fight against pancreatic cancer, offering hope for earlier diagnosis and improved treatment outcomes.
September 5, 2024 — Aclarion, Inc. announces the launch of a program to develop a statewide network of providers in New Jersey to utilize Nociscan throughout the personal injury and workers compensation population, aiming to improve the objective evaluation of chronic low back pain patients. This initiative is expected to impact the financial implications for workers, employers, and insurance companies.
September 5, 2024 — Avadim Holdings, Inc's Theraworx Protect receives an Innovative Technology contract from Vizient, Inc., highlighting its potential to improve healthcare and infection control.
September 4, 2024 — Clene Inc. and its subsidiary, Clene Nanomedicine Inc., to present at the H.C. Wainwright 26th Annual Global Investment Conference and host 1x1 investor meetings. The company is focused on improving mitochondrial health to treat neurodegenerative diseases, including ALS and MS.
September 4, 2024 — American Heart Association and NFL collaborate to promote student physical activity through the NFL PLAY 60 program, emphasizing the importance of physical health and well-being for children. The initiative aims to establish healthy habits at a young age, contributing to longer, healthier lives for students.
September 4, 2024 — Cingulate introduces Precision Timed Release™ (PTR™) technology, revolutionizing drug delivery and addressing underserved medical needs. Learn more about Cingulate's breakthrough on Benzinga's All Access.
September 4, 2024 — Hyro announces the return of Digital Front Door Day, a premier virtual summit dedicated to revolutionizing healthcare access and delivery. The event will feature renowned speakers such as Amir Dan Rubin, former CEO of One Medical, and will include 42 speakers from 32 leading healthcare organizations sharing their insights and case studies.
September 3, 2024 — American Heart Association, Kansas City Chiefs, and NFL launch health and safety programs at Three Trails Elementary School, promoting physical activity, CPR education, and heart health for children.
September 3, 2024 — The PAD Collaborative releases an interactive heat map to highlight the risk of non-traumatic lower limb amputations, a severe complication of peripheral artery disease (PAD), offering specific data for each state and aiming to prevent PAD, reduce complications, and improve quality of life.
September 3, 2024 — PathAI collaborates with GoldPath to elevate digital pathology capabilities with AISight Image Management System. The integration of digital pathology is becoming a critical differentiator for independent laboratories, aiming to reduce turnaround times for referring physicians and deliver cutting-edge pathology services.
September 3, 2024 — Clene (NASDAQ: CLNN) is revolutionizing treatment for neurodegenerative diseases with its lead agent, CNM-Au8, targeting the NAD+ pathway to improve cellular energy production and utilization. Extensive clinical trials have shown CNM-Au8's strong safety profile, positioning Clene as a leader in addressing ALS and MS.
September 3, 2024 — Mainz BioMed CFO discusses the company's commitment to saving lives through early disease detection and prevention, including genetic and genomic tests. Learn more about their progress and promising data from recent trials.
September 3, 2024 — GeoVax Labs CEO to present at investor events, highlighting the latest developments in biotechnology and clinical trials for COVID-19 vaccine and cancer therapy.
September 3, 2024 — Mainz Biomed's breakthrough colorectal cancer test offers hope for improved early detection and survival rates, potentially impacting the multi-billion dollar U.S. market for colorectal screening and expanding into other gastrointestinal cancers.